We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBIO
1101
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3K ﹤0.01%
287
-363
-56% -$2.78K
AMAG
1102
DELISTED
AMAG Pharmaceuticals
AMAG
$3K ﹤0.01%
195
FTSV
1103
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$3K ﹤0.01%
198
-102
-34% -$1.62K
ARQL
1104
DELISTED
Arqule Inc
ARQL
$3K ﹤0.01%
+712
New +$2.75K
PDLI
1105
DELISTED
PDL BioPharma, Inc.
PDLI
$3K ﹤0.01%
853
ADVM
1106
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
+41
New +$1.66K
ASRT
1107
DELISTED
Assertio
ASRT
$2K ﹤0.01%
6
CLLS
1108
Cellectis
CLLS
$289M
$2K ﹤0.01%
100
+51
+104% +$904
CRBP icon
1109
Corbus Pharmaceuticals
CRBP
$174M
$2K ﹤0.01%
10
CTMX icon
1110
CytomX Therapeutics
CTMX
$738M
$2K ﹤0.01%
212
CYTK icon
1111
Cytokinetics
CYTK
$10.9B
$2K ﹤0.01%
298
HLF icon
1112
PUT
Herbalife
HLF
$1.25B
$2K ﹤0.01%
500
INO icon
1113
Inovio Pharmaceuticals
INO
$79.8M
$2K ﹤0.01%
42
KNSA icon
1114
Kiniksa Pharmaceuticals
KNSA
$4.89B
$2K ﹤0.01%
+117
New +$2.26K
KPTI icon
1115
Karyopharm Therapeutics
KPTI
$171M
$2K ﹤0.01%
17
MCRB icon
1116
Seres Therapeutics
MCRB
$48.8M
$2K ﹤0.01%
11
MNKD icon
1117
MannKind Corp
MNKD
$1.26B
$2K ﹤0.01%
+1,042
New +$1.65K
MNOV icon
1118
MediciNova
MNOV
$63.5M
$2K ﹤0.01%
268
-332
-55% -$2.9K
NERV icon
1119
Minerva Neurosciences
NERV
$193M
$2K ﹤0.01%
27
RIGL icon
1120
Rigel Pharmaceuticals
RIGL
$695M
$2K ﹤0.01%
81
STIM icon
1121
Neuronetics
STIM
$123M
$2K ﹤0.01%
112
-138
-55% -$2.28K
TLPH icon
1122
Talphera
TLPH
$67.5M
$2K ﹤0.01%
+25
New +$1.46K
UBX
1123
DELISTED
Unity Biotechnology
UBX
$2K ﹤0.01%
27
-13
-33% -$1.47K
XENE icon
1124
Xenon Pharmaceuticals
XENE
$6.33B
$2K ﹤0.01%
+165
New +$1.4K
XERS icon
1125
Xeris Biopharma Holdings
XERS
$1.44B
$2K ﹤0.01%
170
-130
-43% -$1.67K

Similar funds

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.